13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like Chattem, Inc.???s Xyzal Allergy 24HR Launches To OTC Market March 29, 2017 Roivant Licenses Diabetes Drug From Ligand Pharma March 6, 2018 Innate Pharma To Hold Its Annual General Meeting Of Shareholders On June 23, 2017 May 22, 2017
